# EDGAR Filing Document

**Accession Number:** 0001856083
**File Stem:** 0001856083-25-000005
**Filing Date:** 2025-8
**Character Count:** 31596
**Document Hash:** 4b13a171f40c4d654dc962ae39846213
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001856083-25-000005.hdr.sgml**: 20250814

**ACCESSION NUMBER**: 0001856083-25-000005

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250814

**EFFECTIVENESS DATE**: 20250814

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Deep Track Capital, LP
- **CENTRAL INDEX KEY:** 0001856083

**ORGANIZATION NAME:**
- **EIN:** 853360885
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-21949
- **FILM NUMBER:** 251220199

**BUSINESS ADDRESS:**
- **STREET 1:** 200 GREENWICH AVENUE
- **STREET 2:** 3RD FLOOR
- **CITY:** GREENWICH
- **STATE:** CT
- **ZIP:** 06830
- **BUSINESS PHONE:** 2034090812

**MAIL ADDRESS:**
- **STREET 1:** 200 GREENWICH AVENUE
- **STREET 2:** 3RD FLOOR
- **CITY:** GREENWICH
- **STATE:** CT
- **ZIP:** 06830

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0001856083

**Date of Report:** 06/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** Deep Track Capital, LP

**Address:** 200 Greenwich Ave, Greenwich, CT 06830

**Telephone number:** 2034090810

**Name of agent for service:** —

**Agent Address:** —, —, — —

**Reporting Period:** Report for the year ended 06/30/2025

**SEC File Number:** 028-21949

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** —

**Report Type (check only one):**

Institutional Manager.

- [x] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [ ] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 0

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER                   | CUSIP     | MEETING DATE   | VOTE DESCRIPTION                                                                                                                                                                                                                                               | VOTE CATEGORY                |     SHARES VOTED |   SHARES ON LOAN | HOW VOTED   | SHARES VOTED FOR OR AGAINST MANAGEMENT   | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|:---|:---|:---|:---|---:|---:|:---|:---|:---|:---|
| 89BIO, INC.                      | 282559103 | 05/28/2025     | Approval of, on an advisory basis, the compensation of the Company's named executive officers.                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |      9.34558e+06 |                0 | FOR         | 9345578                                  | FOR                         |  |
| ABIVAX SA                        | 00370M103 | 06/06/2025     | Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda item.                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |      3.57921e+06 |                0 | FOR         | 3579209                                  | FOR                         |  |
| ABIVAX SA                        | 00370M103 | 06/06/2025     | Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda item.                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |      3.57921e+06 |                0 | FOR         | 3579209                                  | FOR                         |  |
| AKERO THERAPEUTICS, INC          | 00973Y108 | 06/03/2025     | To consider and act upon a non-binding, advisory vote to approve the compensation of our named executive officers.                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |      1.40781e+06 |                0 | FOR         | 1407806                                  | FOR                         |  |
| ANI PHARMACEUTICALS, INC.        | 00182C103 | 05/22/2025     | To approve the compensation of the Company's named executive officers, on a non-binding, advisory basis.                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES | 773883           |                0 | FOR         | 773883                                   | FOR                         |  |
| APELLIS PHARMACEUTICALS INC.     | 03753U106 | 06/03/2025     | To hold an advisory vote to approve the compensation paid to our named executive officers.                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |      1.50363e+06 |                0 | FOR         | 1503630                                  | FOR                         |  |
| APELLIS PHARMACEUTICALS INC.     | 03753U106 | 06/03/2025     | To hold an advisory vote on the frequency of future advisory votes on the compensation paid to our named executive officers.                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |      1.50363e+06 |                0 | 1 YEAR      | 1503630                                  | FOR                         |  |
| AUTOLUS THERAPEUTICS PLC         | 05280R100 | 06/26/2025     | To approve the Directors' remuneration report (excluding the Directors' remuneration policy set out on pages 39 to 52 of Directors' remuneration report), which is set out on pages 36 to 65 of the 2024 Annual Report and Accounts.                           | SECTION 14A SAY-ON-PAY VOTES |      1.78495e+07 |                0 | FOR         | 17849480                                 | FOR                         |  |
| AVALO THERAPEUTICS INC           | 05338F306 | 06/17/2025     | To approve, on a nonbinding advisory basis, a "Say-on-Pay" resolution regarding the compensensation of our named executive officers.                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES | 844211           |                0 | FOR         | 844211                                   | FOR                         |  |
| AXSOME THERAPEUTICS, INC.        | 05464T104 | 06/06/2025     | To approve, by non-binding advisory vote, the compensation of our named executive officers.                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES | 300000           |                0 | FOR         | 300000                                   | FOR                         |  |
| BICYCLE THERAPEUTICS PLC         | 088786108 | 06/17/2025     | To approve, on advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement.                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES | 485355           |                0 | FOR         | 485355                                   | FOR                         |  |
| BRIDGEBIO PHARMA, INC.           | 10806X102 | 06/20/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES | 473161           |                0 | FOR         | 473161                                   | FOR                         |  |
| CELLDEX THERAPEUTICS, INC.       | 15117B202 | 06/05/2025     | To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement.                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES | 767389           |                0 | FOR         | 767389                                   | FOR                         |  |
| COMPASS PATHWAYS PLC             | 20451W101 | 06/12/2025     | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers for the year ended December 31, 2024.                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |      8.85965e+06 |                0 | FOR         | 8859648                                  | FOR                         |  |
| CYTOKINETICS, INCORPORATED       | 23282W605 | 05/14/2025     | To approve, on an advisory basis, the compensation of Cytokinetics, Incorporated's named executive officers, as disclosed in the Proxy Statement.                                                                                                              | SECTION 14A SAY-ON-PAY VOTES | 564584           |                0 | FOR         | 564584                                   | FOR                         |  |
| DIANTHUS THERAPEUTICS, INC.      | 252828108 | 05/22/2025     | To approve, on an advisory basis, the compensation paid to our named executive officers.                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |      2.34161e+06 |                0 | FOR         | 2341613                                  | FOR                         |  |
| DYNAVAX TECHNOLOGIES CORPORATION | 268158201 | 06/11/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |      1.77905e+07 |                0 | FOR         | 17790486                                 | FOR                         |  |
| DYNE THERAPEUTICS, INC.          | 26818M108 | 05/30/2025     | To vote, on an advisory basis, to approve the compensation of our named executive officers.                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |      2e+06       |                0 | FOR         | 2000000                                  | FOR                         |  |
| DYNE THERAPEUTICS, INC.          | 26818M108 | 05/30/2025     | To hold an advisory vote on the frequency of future advisory votes on the compensation of our named executive officers.                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |      2e+06       |                0 | 1 YEAR      | 2000000                                  | FOR                         |  |
| EDGEWISE THERAPEUTICS INC        | 28036F105 | 06/13/2025     | Conduct an advisory vote on the compensation of our named executive officers.                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |      1.7e+06     |                0 | FOR         | 1700000                                  | FOR                         |  |
| EDGEWISE THERAPEUTICS INC        | 28036F105 | 06/13/2025     | Conduct an advisory vote on the frequency of future advisory votes on the compensation of our named executive officers.                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |      1.7e+06     |                0 | 1 YEAR      | 1700000                                  | FOR                         |  |
| GALAPAGOS N V                    | 36315X101 | 04/29/2025     | Acknowledgement and approval of the remuneration report.                                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |  19778           |                0 | FOR         | 19778                                    | FOR                         |  |
| GENMAB A S                       | 372303206 | 03/12/2025     | Advisory vote on the Compensation Report.                                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES | 358058           |                0 | FOR         | 358058                                   | FOR                         |  |
| GERON CORPORATION                | 374163103 | 05/21/2025     | To approve, on an advisory basis, the compensation of our Named Executive Officers, as disclosed in our Proxy Statement.                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |      1.94501e+07 |                0 | FOR         | 19450111                                 | FOR                         |  |
| GUARDANT HEALTH, INC.            | 40131M109 | 06/18/2025     | Non-binding advisory vote to approve Guardant Health, Inc.'s named executive officer compensation.                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |      3.85786e+06 |                0 | FOR         | 3857860                                  | FOR                         |  |
| H. LUNDBECK A/S                  | K4406L137 | 03/26/2025     | THE BOARD OF DIRECTORS RECOMMENDS THAT THE REPORT BE APPROVED. PRESENTATION OF AND ADVISORY VOTE ON THE REMUNERATION REPORT                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |      0           |          2169386 |  |  |  |  |
| IMMUNOCORE HOLDINGS PLC          | 45258D105 | 05/15/2025     | To approve, on advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |      1.29045e+06 |                0 | FOR         | 1290453                                  | FOR                         |  |
| IMMUNOVANT INC                   | 45258J102 | 08/12/2024     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |      1.98149e+06 |                0 | FOR         | 1981490                                  | FOR                         |  |
| INOVIO PHARMACEUTICALS, INC.     | 45773H409 | 05/20/2025     | To approve, on a non-binding advisory basis, the resolution regarding compensation of our named executive officers described in the accompanying proxy statement.                                                                                              | SECTION 14A SAY-ON-PAY VOTES |      1.67625e+06 |                0 | FOR         | 1676254                                  | FOR                         |  |
| INTRA-CELLULAR THERAPIES, INC.   | 46116X101 | 03/27/2025     | To approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to ITI's named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement. | SECTION 14A SAY-ON-PAY VOTES |      2e+06       |                0 | FOR         | 2000000                                  | FOR                         |  |
| IONIS PHARMACEUTICALS, INC.      | 462222100 | 06/05/2025     | To make an advisory vote on executive compensation.                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |      4.93378e+06 |                0 | FOR         | 4933784                                  | FOR                         |  |
| JANUX THERAPEUTICS, INC.         | 47103J105 | 06/11/2025     | Approval, on an advisory basis, of the compensation of our named executive officers ("Say-On-Pay"), as disclosed in the accompanying Proxy Statement.                                                                                                          | SECTION 14A SAY-ON-PAY VOTES | 209881           |                0 | FOR         | 209881                                   | FOR                         |  |
| JANUX THERAPEUTICS, INC.         | 47103J105 | 06/11/2025     | Indication, on an advisory basis, of the preferred frequency of holding future Say-On-Pay votes on the compensation of our named executive officers.                                                                                                           | SECTION 14A SAY-ON-PAY VOTES | 209881           |                0 | 1 YEAR      | 209881                                   | FOR                         |  |
| KORRO BIO, INC.                  | 500946108 | 06/11/2025     | Non-Binding Advisory Vote to Approve the Compensation of our Named Executive Officers.                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES | 865186           |                0 | FOR         | 865186                                   | FOR                         |  |
| KORRO BIO, INC.                  | 500946108 | 06/11/2025     | Non-Binding Advisory Vote on the Frequency of Future Non-Binding Advisory Votes to Approve the Compensation of our Named Executive Officers                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES | 865186           |                0 | 1 YEAR      | 865186                                   | FOR                         |  |
| NOVAVAX, INC.                    | 670002401 | 06/20/2025     | The approval, on an advisory basis, of the compensation of our Named Executive Officers.                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |      1.21592e+06 |                0 | FOR         | 1215925                                  | FOR                         |  |
| NURIX THERAPEUTICS, INC.         | 67080M103 | 05/19/2025     | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement.                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |      3.45291e+06 |                0 | FOR         | 3452910                                  | FOR                         |  |
| OCULAR THERAPEUTIX, INC.         | 67576A100 | 06/11/2025     | To approve an advisory vote on named executive officer compensation.                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |      1.42174e+07 |                0 | FOR         | 14217442                                 | FOR                         |  |
| OLEMA PHARMACEUTICALS, INC.      | 68062P106 | 06/10/2025     | Approval, on an advisory basis, of the compensation of the Company's named executive officers.                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |      3.44283e+06 |                0 | FOR         | 3442833                                  | FOR                         |  |
| ORUKA THERAPEUTICS, INC.         | 687604108 | 06/02/2025     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |      1.68385e+06 |                0 | FOR         | 1683848                                  | FOR                         |  |
| ORUKA THERAPEUTICS, INC.         | 687604108 | 06/02/2025     | To vote, on a non-binding, advisory basis, on the frequency of future advisory votes to approve compensation for our named executive officers.                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |      1.68385e+06 |                0 | 1 YEAR      | 1683848                                  | FOR                         |  |
| PLIANT THERAPEUTICS, INC.        | 729139105 | 06/05/2025     | To approve, by non-binding advisory vote, the resolution approving Named Executive Officer compensation.                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |      5.39968e+06 |                0 | FOR         | 5399681                                  | FOR                         |  |
| PROTAGONIST THERAPEUTICS, INC.   | 74366E102 | 06/20/2025     | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |      3.25e+06    |                0 | FOR         | 3250000                                  | FOR                         |  |
| RAPT THERAPEUTICS, INC.          | 75382E109 | 05/29/2025     | To approve, on an advisory basis, the compensation of RAPT Therapeutics, Inc.'s named executive officers.                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |      6.01138e+06 |                0 | FOR         | 6011380                                  | FOR                         |  |
| RAPT THERAPEUTICS, INC.          | 75382E109 | 05/29/2025     | To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of RAPT Therapeutics, Inc.'s named executive officers.                                                                                            | SECTION 14A SAY-ON-PAY VOTES |      6.01138e+06 |                0 | 1 YEAR      | 6011380                                  | FOR                         |  |
| SAGE THERAPEUTICS, INC.          | 78667J108 | 06/11/2025     | To hold a non-binding advisory vote to approve the compensation paid to our named executive officers.                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |      2.49851e+06 |                0 | FOR         | 2498505.3259                             | FOR                         |  |
| SAREPTA THERAPEUTICS, INC.       | 803607100 | 06/05/2025     | ADVISORY VOTE TO APPROVE, ON A NON-BINDING BASIS, NAMED EXECUTIVE OFFICER COMPENSATION                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES | 899731           |                0 | FOR         | 899731                                   | FOR                         |  |
| SPYRE THERAPEUTICS INC.          | 00773J202 | 05/29/2025     | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES | 219015           |                0 | FOR         | 219015                                   | FOR                         |  |
| STRUCTURE THERAPEUTICS, INC.     | 86366E106 | 06/23/2025     | TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE PROXY STATEMENT.                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |      4.5e+06     |                0 | FOR         | 4500000                                  | FOR                         |  |
| STRUCTURE THERAPEUTICS, INC.     | 86366E106 | 06/23/2025     | TO INDICATE, ON AN ADVISORY BASIS, THE PREFERRED FREQUENCY OF SHAREHOLDER ADVISORY VOTES ON THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |      4.5e+06     |                0 | 1 YEAR      | 4500000                                  | FOR                         |  |
| TARSUS PHARMACEUTICALS, INC.     | 87650L103 | 06/12/2025     | To hold an advisory vote to approve, on a non-binding basis, named executive officer compensation.                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES | 791029           |                0 | FOR         | 791029                                   | FOR                         |  |
| TARSUS PHARMACEUTICALS, INC.     | 87650L103 | 06/12/2025     | To hold an advisory vote to approve, on a non-binding basis, the frequency with which future stockholder votes on the compensation of our named executive officers will be conducted of one, two or three years.                                               | SECTION 14A SAY-ON-PAY VOTES | 791029           |                0 | 1 YEAR      | 791029                                   | FOR                         |  |
| TECTONIC THERAPEUTIC, INC        | 878972108 | 06/06/2025     | Advisory approval of the compensation of the Company's Named Executive Officers.                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |      1.40194e+06 |                0 | FOR         | 1401938                                  | FOR                         |  |
| TECTONIC THERAPEUTIC, INC        | 878972108 | 06/06/2025     | Advisory vote on the frequency of stockholder advisory votes on executive compensation.                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |      1.40194e+06 |                0 | 1 YEAR      | 1401938                                  | FOR                         |  |
| ULTRAGENYX PHARMACEUTICAL INC.   | 90400D108 | 05/15/2025     | Advisory (non-binding) vote to approve the compensation of our named executive officers.                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |      1.35e+06    |                0 | FOR         | 1350000                                  | FOR                         |  |
| VAXCYTE, INC.                    | 92243G108 | 06/12/2025     | Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |      1.55739e+06 |                0 | FOR         | 1557391                                  | FOR                         |  |
| VIRIDIAN THERAPEUTICS, INC.      | 92790C104 | 06/20/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers.                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |      2.52666e+06 |                0 | FOR         | 2526662                                  | FOR                         |  |
| XENCOR, INC.                     | 98401F105 | 06/12/2025     | To approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers, as disclosed in the accompanying Proxy Statement.                                                                                                  | SECTION 14A SAY-ON-PAY VOTES | 549439           |                0 | FOR         | 549439                                   | FOR                         |  |
| XENON PHARMACEUTICALS INC        | 98420N105 | 06/04/2025     | To approve, on an advisory basis, the compensation of the Corporation's named executive officers.                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |      1e+06       |                0 | FOR         | 1000000                                  | FOR                         |  |

## N-PX: Signature Block

**Reporting Person:** Deep Track Capital, LP

**By (Signature):** Nir Messafi

**By (Printed Signature):** Nir Messafi

**By (Title):** Chief Compliance Officer

**Date:** 08/14/2025